These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24940736)

  • 1. Cardiac high-energy phosphate metabolism alters with age as studied in 196 healthy males with the help of 31-phosphorus 2-dimensional chemical shift imaging.
    Esterhammer R; Klug G; Wolf C; Mayr A; Reinstadler S; Feistritzer HJ; Metzler B; Schocke MF
    PLoS One; 2014; 9(6):e97368. PubMed ID: 24940736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI).
    Schocke MF; Metzler B; Wolf C; Steinboeck P; Kremser C; Pachinger O; Jaschke W; Lukas P
    Magn Reson Imaging; 2003 Jun; 21(5):553-9. PubMed ID: 12878266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis.
    Schocke MF; Zoller H; Vogel W; Wolf C; Kremser C; Steinboeck P; Poelzl G; Pachinger O; Jaschke WR; Metzler B
    Magn Reson Imaging; 2004 May; 22(4):515-21. PubMed ID: 15120171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors improve myocardial high-energy phosphate metabolism in men.
    Schocke MF; Martinek M; Kremser C; Wolf C; Steinboeck P; Lechleitner M; Jaschke W; Pachinger O; Metzler B
    J Cardiovasc Magn Reson; 2003; 5(4):595-602. PubMed ID: 14664137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I.
    Metzler B; Schocke MF; Steinboeck P; Wolf C; Judmaier W; Lechleitner M; Lukas P; Pachinger O
    J Cardiovasc Magn Reson; 2002; 4(4):493-502. PubMed ID: 12549236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
    Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
    J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia.
    Wolf C; Boesch S; Metzler B; Weirich-Schwaiger H; Trieb T; Schocke MF
    Mol Imaging Biol; 2008; 10(1):24-9. PubMed ID: 18000714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of altered myocardial high energy phosphate metabolism in patients on maintenance dialysis using phosphorus-31 magnetic resonance spectroscopy.
    Tagami T; Sakuma H; Matsumura K; Takeda K; Mori S; Takeuchi T; Nakano T
    Invest Radiol; 1998 Mar; 33(3):171-6. PubMed ID: 9525756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
    Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
    Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
    Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
    Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
    Beer M; Wagner D; Myers J; Sandstede J; Köstler H; Hahn D; Neubauer S; Dubach P
    J Am Coll Cardiol; 2008 May; 51(19):1883-91. PubMed ID: 18466804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
    Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
    J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease.
    Leme AM; Salemi VM; Parga JR; Ianni BM; Mady C; Weiss RG; Kalil-Filho R
    Arq Bras Cardiol; 2010 Aug; 95(2):264-70. PubMed ID: 20676586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS.
    Okada M; Mitsunami K; Inubushi T; Kinoshita M
    Magn Reson Med; 1998 May; 39(5):772-82. PubMed ID: 9581609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiabatic excitation for
    Valkovič L; Clarke WT; Purvis LAB; Schaller B; Robson MD; Rodgers CT
    Magn Reson Med; 2017 Nov; 78(5):1667-1673. PubMed ID: 28000961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of energy production by the heart in CRF patients undergoing peritoneal dialysis.
    Ogimoto G; Sakurada T; Imamura K; Kuboshima S; Maeba T; Kimura K; Owada S
    Mol Cell Biochem; 2003 Feb; 244(1-2):135-8. PubMed ID: 12701822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
    Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
    Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
    Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
    Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of exercise capacity on myocardial high-energy phosphate metabolism.
    Klug G; Zwick RH; Frick M; Wolf C; Schocke MF; Conci E; Jaschke W; Pachinger O; Metzler B
    Int J Sports Med; 2007 Aug; 28(8):667-72. PubMed ID: 17455117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.